SynthesisFrontiers in pharmacology2023

Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.

Xuan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.